Portfolio
Corner Office
Culture
Premium
Opinion
Events
Video
Innovation
Subscribe
Sign In
Register
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Events
Video
Innovation
Subscribe
Sign In
Register
Search Query
Submit Search
Show Search
Vitaliy Katsenelson
Latest articles
Corner Office
What Not to Buy in Today’s Stock Market
Vitaliy Katsenelson
April 18, 2017
Corner Office
Why Cognizant Shines Brighter as a Stock Pick
Vitaliy Katsenelson
March 24, 2017
Portfolio
The Pharma Stocks We’re Buying Now
Vitaliy Katsenelson
March 8, 2017
Portfolio
The Sector Politicians Love to Hate — and Why We’re Buying It
Vitaliy Katsenelson
March 2, 2017
Portfolio
Trump May Equal Volatility, but Volatility Doesn’t Equal Risk
Vitaliy Katsenelson
February 10, 2017
Portfolio
The Persistent Problems of Presidential Elections
Vitaliy Katsenelson
November 11, 2016
Portfolio
How Cord-Cutters Made Discovery Communications a Great Value
Vitaliy Katsenelson
October 28, 2016
Opinion
The Dangers of Dividend Obsession
Vitaliy Katsenelson
October 16, 2016
Portfolio
Good Companies Don’t Always Make Good Stocks
Vitaliy Katsenelson
September 26, 2016
Portfolio
Searching for Yield? Better to Look for Humility and Patience
Vitaliy Katsenelson
August 10, 2016
Portfolio
SoftBank CEO Masayoshi Son Banks on Exponential Growth
Vitaliy Katsenelson
July 27, 2016
Portfolio
The Values of Value Investing
Vitaliy Katsenelson
July 7, 2016
Portfolio
Time for an All-Terrain Investment Portfolio
Vitaliy Katsenelson
May 24, 2016
Portfolio
For Investors, Discovering Truth Takes Time
Vitaliy Katsenelson
April 8, 2016
Portfolio
Jos. A. Bank and the Folly of Quantitative Easing
Vitaliy Katsenelson
March 29, 2016
Portfolio
Whatever Happened to the Invisible Hand of Capitalism?
Vitaliy Katsenelson
March 16, 2016
Portfolio
Gilead Sciences’ Miracle Drug Combination
Vitaliy Katsenelson
February 23, 2016
Portfolio
How to Invest the Dale Carnegie Way
Vitaliy Katsenelson
January 26, 2016